Get started
Author

Davide Facchinelli

Observed names: D. Facchinelli, Facchinelli, Davide
Observed institutions: University of Verona, Azienda Ospedaliera Universitaria Integrata Verona, Ospedale San Bortolo, Istituto Imaging della Svizzera Italiana, Istituto Oncologico della Svizzera Italiana, Azienda ULSS 8 Berica
ORCID: 0000-0002-7581-5824
Observed ORCID: 0000-0002-7581-5824
OpenAlex ID: A5068408771
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients
2016 · Olivia Marini, Cecilia Spina, et al. · Oncotarget · 92
Efficacy and toxicity of Decitabine in patients with acute myeloid leukemia (AML): A multicenter real-world experience
2018 · Carla Filì, Anna Candoni, et al. · Leukemia Research · 41
Primary Pancreatic Lymphoma: Recommendations for Diagnosis and Management
2021 · Davide Facchinelli, Enrico Boninsegna, et al. · Journal of Blood Medicine · 37
PDF
Primary pancreatic lymphoma: Clinical presentation, diagnosis, treatment, and outcome
2020 · Davide Facchinelli, Sokol Sina, et al. · European Journal Of Haematology · 34
CT imaging of primary pancreatic lymphoma: experience from three referral centres for pancreatic diseases
2018 · Enrico Boninsegna, Giulia A. Zamboni, et al. · Insights into Imaging · 33
PDF
Prognostic models integrating quantitative parameters from baseline and interim positron emission computed tomography in patients with diffuse large B‐cell lymphoma: post‐hoc analysis from the SAKK38/07 clinical trial
2020 · Emanuele Zucca, Luciano Cascione, et al. · Hematological Oncology · 29
Invasive Fungal Infections in Patients With Chronic Lymphoproliferative Disorders in the Era of Target Drugs
2018 · Livio Pagano, Davide Facchinelli · Mediterranean Journal of Hematology and Infectious Diseases · 23
PDF
Infections in patients with lymphoproliferative diseases treated with targeted agents: SEIFEM multicentric retrospective study
2020 · Gessica Marchesini, Gianpaolo Nadali, et al. · British Journal of Haematology · 18
PDF
High Incidence of Invasive Fungal Diseases in Patients with FLT3-Mutated AML Treated with Midostaurin: Results of a Multicenter Observational SEIFEM Study
2022 · Chiara Cattaneo, Francesco Marchesi, et al. · Journal of Fungi · 17
PDF
Rituximab and Bendamustine (BR) Compared with Rituximab, Bendamustine, and Cytarabine (R-BAC) in Previously Untreated Elderly Patients with Mantle Cell Lymphoma
2021 · Giulia Bega, Jacopo Olivieri, et al. · Cancers · 16
PDF
A successful treatment-free remission is achievable also by chronic myeloid leukemia patients lacking optimal requirements
2024 · Massimiliano Bonifacio, Luigi Scaffidi, et al. · Blood Cancer Journal · 10
PDF
Two cases of angioimmunoblastic T-cell lymphoma with concomitant positive serology for acute Epstein-Barr virus infection
2017 · Davide Facchinelli, Angela Polino, et al. · Hematology Reports · 7
PDF
Infections in patients with lymphoproliferative diseases treated with brentuximab vedotin: SEIFEM multicentric retrospective study
2020 · Gessica Marchesini, Gianpaolo Nadali, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 6
Infections in Patients with Lymphoproliferative Diseases Treated with Target Therapy. Italian Multicentric Retrospective Study Seifem 2017
2018 · Gianpaolo Nadali, Gessica Marchesini, et al. · Blood · 5
Venetoclax infectious risk score to identify patients with chronic lymphocytic leukemia at high infectious risk during venetoclax treatment: A multicenter SEIFEM study
2024 · Francesco Autore, Andrea Visentin, et al. · American Journal of Hematology · 3
PDF
Isolated cerebellar progressive multifocal leukoencephalopathy after allogeneic bone marrow transplantation: focus on imaging
2021 · Linda Mazzai, Davide Facchinelli, et al. · Tumori Journal · 3
Sciatic pain by neurolymphomatosis as initial presentation of disseminated diffuse large B cell lymphoma involving the testis and the CNS
2020 · Davide Facchinelli, Esteban Ciliberti, et al. · Hematological Oncology · 3
Blood smear, a key diagnostic tool in hematology: Lessons from two cases of acute hemolysis in previously undiagnosed G6PD deficiency
2016 · Dino Veneri, Davide Facchinelli, et al. · American Journal of Hematology · 3
PDF
Assessment of Transitioning from High-Potency to Low-Potency Inhibitors in Chronic Myeloid Leukemia (CML) Patients: The Downgrading-Impact (D-IMPACT) Project
2026 · Elisabetta Abruzzese, Monica Crugnola, et al. · Cancers · 2
Characteristics and Outcomes of Progressive Multifocal Leukoencephalopathy in Hematologic Malignancies: A SEIFEM Retrospective Review
2026 · Davide Facchinelli, Linda Mazzai, et al. · American Journal of Hematology · 2
Improved Detection of Minimal Residual Disease in AML: Validation of IDH1/2 ddPCR Assays in the Perspective of Treatment with Target Inhibitors
2025 · Katsiaryna Nikitsenka, Giacomo Danieli, et al. · International Journal of Molecular Sciences · 2
PDF
Palliative care is related to less aggressive end-of-life treatment in haematology-oncology: a retrospective cohort study
2025 · Davide Facchinelli, Corinna Greco, et al. · BMJ Supportive & Palliative Care · 2
Impact of COVID-19 in Patients with Chronic Lymphocytic Leukemia Treated with Venetoclax: A Possible Role of the Association to Anti-CD20 Antibody? a Multicentre Seifem Study
2023 · Francesco Autore, Andrea Visentin, et al. · Blood · 2
PDF
Chronic Obstructive Pulmonary Disease and Previous Infections Have Impact on Infectious Complications in Patients with Chronic Lymphocytic Leukemia Treated with Venetoclax: A Multicentre Seifem Study
2023 · Francesco Autore, Andrea Visentin, et al. · Blood · 2
Assessment of Transitioning from High-Potency to Low-Potency Inhibitors in Chronic Myeloid Leukemia (CML) Patients: The Downgrading-Impact Project, a CML Campus Study
2024 · Elisabetta Abruzzese, Simona Bernardi, et al. · Blood · 1
PDF
Works count: 46
Citation count: 401
H-index: 10
I10-index: 11
Year
Topic
Type